Gene Bio Tech Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
204
146
584
2,535
1,847
Depreciation, Depletion & Amortization
1,470
1,425
1,481
1,514
1,507
Funds from Operations
1,995
2,909
3,437
5,361
4,692
Changes in Working Capital
145
674
744
75
3,615
Net Operating Cash Flow
2,140
2,235
2,693
5,286
1,077
Capital Expenditures
584
518
927
1,296
1,206
Sale of Fixed Assets & Businesses
17
111
16
151
23
Purchase/Sale of Investments
1,689
55
174
1,037
4,433
Net Investing Cash Flow
1,997
415
636
9
5,687
Cash Dividends Paid - Total
175
204
211
250
258
Issuance/Reduction of Debt, Net
1,279
2,163
1,346
3,174
1,709
Net Financing Cash Flow
2,243
2,368
61
2,426
1,451
Net Change in Cash
2,386
547
1,993
2,894
3,231
Free Cash Flow
1,558
1,724
1,767
3,996
30
Other Sources
360
172
123
121
146
Change in Capital Stock
1,139
-
1,496
999
-
Exchange Rate Effect
-
1
3
26
72
Other Uses
100
125
22
5
216
About Gene Bio Tech Co.
View Profile
